Olivia Bennett is an associate in Ropes & Gray’s antitrust team, advising clients on EU and UK competition law matters. 

Olivia trained at the firm’s London office, gaining experience in the asset management, private equity, antitrust, and litigation & enforcement practice groups.

Experience

  • Advising Bain Capital on its:
    • definitive agreement to acquire Envestnet for $4.5 billion
    • acquisition of Evident Corporation
  • Acting for TPG in connection with its:
    • $4 billion sale of Wind River to Aptiv
    • acquisition of a majority interest in Outcomes First Group
  • Acting for Berkshire Partners in its:
    • acquisition of a majority stake in AHEAD
    • growth investment in PDQ
  • Represented AvenCell Therapeutics in its $112 million Series B funding round led by global life sciences investor Novo Holdings.

Areas of Practice